Spruce Biosciences Ownership 2024 | Who Owns Spruce Biosciences Now?
Institutional Ownership
40.33%
Insider Ownership
7.72%
Retail Ownership
51.95%
Institutional Holders
40.00
Spruce Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RIVERVEST VENTURE MANAGEMENT LLC | 7.14% | 22.27% | 2,936,281 | - | - | 1,520,114 | Jun 30, 2024 |
| CARLYLE GROUP INC. | 7.05% | 0.14% | 2,896,518 | - | - | 1,520,093 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 6.35% | 0.04% | 2,609,125 | - | - | 1,350,744 | Jun 30, 2024 |
| ROSALIND ADVISORS, INC. | 3.67% | 0.60% | 1,508,419 | - | - | 780,908 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 3.33% | 0.00% | 1,367,997 | 999,166 | 270.90% | 707,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.10% | - | 863,375 | - | - | 446,969 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 1.97% | 0.17% | 811,167 | -338,833 | -29.46% | 419,941 | Jun 30, 2024 |
| SANDS CAPITAL VENTURES, LLC | 1.92% | 0.14% | 787,007 | - | - | 409,244 | Jun 30, 2024 |
| ALMITAS CAPITAL LLC | 0.96% | 0.09% | 396,506 | 396,506 | 100.00% | 205,271 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.94% | 0.00% | 386,702 | 161,869 | 72.00% | 200,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.89% | 0.00% | 366,100 | 95,100 | 35.09% | 189,530 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.86% | 0.03% | 355,216 | -10,000 | -2.74% | 183,895 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.50% | - | 204,002 | 3,840 | 1.92% | 105,636 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 0.34% | 0.01% | 140,934 | 140,934 | 100.00% | 72,961 | Jun 30, 2024 |
| UBS GROUP AG | 0.32% | - | 131,923 | 116,109 | 734.22% | 68,336 | Jun 30, 2024 |
| BLACKROCK INC. | 0.30% | - | 124,734 | -61,214 | -32.92% | 64,575 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.21% | 0.00% | 85,000 | - | - | 44,005 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.19% | 0.05% | 77,992 | -362,233 | -82.28% | 40,376 | Jun 30, 2024 |
| LION POINT CAPITAL, LP | 0.18% | 0.07% | 75,000 | - | - | 38,828 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.18% | - | 74,927 | -28 | -0.04% | 38,790,000 | Jun 30, 2024 |
Spruce Biosciences's largest institutional shareholder is RIVERVEST VENTURE MANAGEMENT LLC, holding 7.14% of the company's total share outstanding, currently valued at $1.52M. The top 10 institutional shareholders own together 35.44% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RIVERVEST VENTURE MANAGEMENT LLC | 7.14% | 22.27% | 2,936,281 | - | - | 1,520,114 | Jun 30, 2024 |
| ROSALIND ADVISORS, INC. | 3.67% | 0.60% | 1,508,419 | - | - | 780,908 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 1.97% | 0.17% | 811,167 | -338,833 | -29.46% | 419,941 | Jun 30, 2024 |
| CARLYLE GROUP INC. | 7.05% | 0.14% | 2,896,518 | - | - | 1,520,093 | Jun 30, 2024 |
| SANDS CAPITAL VENTURES, LLC | 1.92% | 0.14% | 787,007 | - | - | 409,244 | Jun 30, 2024 |
| ALMITAS CAPITAL LLC | 0.96% | 0.09% | 396,506 | 396,506 | 100.00% | 205,271 | Jun 30, 2024 |
| LION POINT CAPITAL, LP | 0.18% | 0.07% | 75,000 | - | - | 38,828 | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.19% | 0.05% | 77,992 | -362,233 | -82.28% | 40,376 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 6.35% | 0.04% | 2,609,125 | - | - | 1,350,744 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.86% | 0.03% | 355,216 | -10,000 | -2.74% | 183,895 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 0.34% | 0.01% | 140,934 | 140,934 | 100.00% | 72,961 | Jun 30, 2024 |
| PRIVIUM FUND MANAGEMENT (UK) LTD | 0.06% | 0.01% | 24,554 | - | - | 12,947 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 3.33% | 0.00% | 1,367,997 | 999,166 | 270.90% | 707,000 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.94% | 0.00% | 386,702 | 161,869 | 72.00% | 200,000 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.07% | 0.00% | 27,185 | -29,562 | -52.09% | 14,074 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.21% | 0.00% | 85,000 | - | - | 44,005 | Jun 30, 2024 |
| SHAY CAPITAL LLC | 0.03% | 0.00% | 13,172 | 13,172 | 100.00% | 6,819 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.89% | 0.00% | 366,100 | 95,100 | 35.09% | 189,530 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.08% | 0.00% | 33,087 | 21,660 | 189.55% | 17,139 | Jun 30, 2024 |
| CALDWELL SUTTER CAPITAL, INC. | 0.00% | 0.00% | 1,000 | - | - | 518 | Jun 30, 2024 |
The largest Spruce Biosciences shareholder by % of total assets is RIVERVEST VENTURE MANAGEMENT LLC. The company owns 2.94M shares of Spruce Biosciences (SPRB), representing 22.27% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ACADIAN ASSET MANAGEMENT LLC | 3.33% | 0.00% | 1,367,997 | 999,166 | 270.90% | 707,000 | Jun 30, 2024 |
| ALMITAS CAPITAL LLC | 0.96% | 0.09% | 396,506 | 396,506 | 100.00% | 205,271 | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.94% | 0.00% | 386,702 | 161,869 | 72.00% | 200,000 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 0.34% | 0.01% | 140,934 | 140,934 | 100.00% | 72,961 | Jun 30, 2024 |
| UBS GROUP AG | 0.32% | - | 131,923 | 116,109 | 734.22% | 68,336 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.89% | 0.00% | 366,100 | 95,100 | 35.09% | 189,530 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.08% | 0.00% | 33,087 | 21,660 | 189.55% | 17,139 | Jun 30, 2024 |
| SHAY CAPITAL LLC | 0.03% | 0.00% | 13,172 | 13,172 | 100.00% | 6,819 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.50% | - | 204,002 | 3,840 | 1.92% | 105,636 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.00% | - | 72 | 61 | 554.55% | 38 | Jun 30, 2024 |
| STATE STREET CORP | 0.16% | - | 64,400 | - | - | 33,340,000 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.04% | - | 15,289 | - | - | 7,915 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.10% | - | 863,375 | - | - | 446,969 | Jun 30, 2024 |
| CALDWELL SUTTER CAPITAL, INC. | 0.00% | 0.00% | 1,000 | - | - | 518 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.21% | 0.00% | 85,000 | - | - | 44,005 | Jun 30, 2024 |
| PRIVIUM FUND MANAGEMENT (UK) LTD | 0.06% | 0.01% | 24,554 | - | - | 12,947 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 6.35% | 0.04% | 2,609,125 | - | - | 1,350,744 | Jun 30, 2024 |
| LION POINT CAPITAL, LP | 0.18% | 0.07% | 75,000 | - | - | 38,828 | Jun 30, 2024 |
| SANDS CAPITAL VENTURES, LLC | 1.92% | 0.14% | 787,007 | - | - | 409,244 | Jun 30, 2024 |
| CARLYLE GROUP INC. | 7.05% | 0.14% | 2,896,518 | - | - | 1,520,093 | Jun 30, 2024 |
As of Jun 30 2024, Spruce Biosciences's largest institutional buyer is ACADIAN ASSET MANAGEMENT LLC. The company purchased 999.17K stocks of SPRB, valued at $707.00K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AISLING CAPITAL MANAGEMENT LP | - | - | - | -1,205,511 | -100.00% | - | Jun 30, 2024 |
| SUPERSTRING CAPITAL MANAGEMENT LP | 0.19% | 0.05% | 77,992 | -362,233 | -82.28% | 40,376 | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | 1.97% | 0.17% | 811,167 | -338,833 | -29.46% | 419,941 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | - | - | - | -253,682 | -100.00% | - | Jun 30, 2024 |
| AWM INVESTMENT COMPANY, INC. | - | - | - | -200,000 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -178,958 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -102,223 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.07% | - | 28,584 | -94,429 | -76.76% | 14,798 | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -72,245 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | 0.30% | - | 124,734 | -61,214 | -32.92% | 64,575 | Jun 30, 2024 |
| CASTLEVIEW PARTNERS, LLC | - | - | - | -59,709 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -46,664 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 2 | -39,594 | -99.99% | 1 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -39,100 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | 0.07% | 0.00% | 27,185 | -29,562 | -52.09% | 14,074 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -28,100 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -26,016 | -100.00% | - | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 150 | -25,980 | -99.43% | 78 | Jun 30, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -24,900 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -22,508 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Spruce Biosciences's biggest institutional seller is AISLING CAPITAL MANAGEMENT LP. The company sold -1.21M shares of SPRB, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALMITAS CAPITAL LLC | 0.96% | 0.09% | 396,506 | 396,506 | 100.00% | 205,271 | Jun 30, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | 0.34% | 0.01% | 140,934 | 140,934 | 100.00% | 72,961 | Jun 30, 2024 |
| SHAY CAPITAL LLC | 0.03% | 0.00% | 13,172 | 13,172 | 100.00% | 6,819 | Jun 30, 2024 |
Spruce Biosciences's largest new institutional shareholder by number of shares is ALMITAS CAPITAL LLC, purchased 396.51K shares, valued at $205.27K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AISLING CAPITAL MANAGEMENT LP | - | - | - | -1,205,511 | -100.00% | - | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | - | - | - | -253,682 | -100.00% | - | Jun 30, 2024 |
| AWM INVESTMENT COMPANY, INC. | - | - | - | -200,000 | -100.00% | - | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | - | - | - | -178,958 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -102,223 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -72,245 | -100.00% | - | Jun 30, 2024 |
| CASTLEVIEW PARTNERS, LLC | - | - | - | -59,709 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -46,664 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -39,100 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -28,100 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -26,016 | -100.00% | - | Jun 30, 2024 |
| BELVEDERE TRADING LLC | - | - | - | -24,900 | -100.00% | - | Jun 30, 2024 |
| BALYASNY ASSET MANAGEMENT L.P. | - | - | - | -22,508 | -100.00% | - | Jun 30, 2024 |
| OMERS ADMINISTRATION CORP | - | - | - | -16,000 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -143 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | - | - | - | -103 | -100.00% | - | Jun 30, 2024 |
Spruce Biosciences's largest sold out institutional shareholder by shares sold is AISLING CAPITAL MANAGEMENT LP, sold -1.21M shares, valued at -, as of undefined.
Spruce Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BRIDGEWAY FUNDS INC | 0.04% | 85,000 | - | - | Mar 28, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 438,225 | - | - | Feb 29, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.00% | 690 | - | - | Mar 28, 2024 |
| Humankind Benefit Corp | 0.00% | 78 | - | - | Dec 31, 2023 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 99,469 | - | - | Feb 29, 2024 |
| ALPS ETF Trust | 0.00% | 27,696 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 835,745 | -170,477 | -16.94% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 1,143 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 9,625 | - | - | Mar 31, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 13,400 | - | - | Mar 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 178,136 | 48,504 | 37.42% | Feb 29, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 19,531 | 9,866 | 102.08% | Mar 31, 2024 |
| Voya INVESTORS TRUST | 0.00% | 22,400 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 15,289 | - | - | Jan 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 584 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 24,568 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 2,972 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 221 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 2,093 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 2,611 | - | - | Jan 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 25,043 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 4,932 | - | - | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 762 | - | - | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 2,883 | 2,883 | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 285 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 1,500 | - | - | Mar 31, 2024 |
| JPMorgan Trust I | 0.00% | 26,128 | - | - | Jan 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 82 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 186 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 61,278 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 29,490 | - | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 1,400 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 46 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 3,219 | - | - | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 1,457 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 2,235 | - | - | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 51 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 8,720 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 8 | - | - | Dec 31, 2023 |
| PROSHARES TRUST | 0.00% | 1,260 | - | - | Feb 29, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 4,185 | -12,483 | -74.89% | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 396 | - | - | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 11,422 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 4,228 | -472 | -10.04% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 56,986 | 1,723 | 3.12% | Mar 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 1,043 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 7,900 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 958 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 48 | - | - | Jan 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 4,781 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 876 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 3,007 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 637 | -821 | -56.31% | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 735 | - | - | Feb 29, 2024 |
Spruce Biosciences's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 85.00K shares, compromising 0.04% of its total assets.
Spruce Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 40 | -24.53% |
| 31 Mar, 24 | 53 | 32.50% |
| 31 Dec, 23 | 40 | -2.44% |
| 30 Sep, 23 | 41 | 2.50% |
| 30 Jun, 23 | 40 | -6.98% |
| 31 Mar, 23 | 43 | 43.33% |
| 31 Dec, 22 | 30 | -6.25% |
| 30 Sep, 22 | 32 | 3.23% |
| 30 Jun, 22 | 31 | -27.91% |
| 31 Mar, 22 | 43 | -14.00% |
| 31 Dec, 21 | 50 | 16.28% |
| 30 Sep, 21 | 43 | 4.88% |
| 30 Jun, 21 | 41 | 2.50% |
| 31 Mar, 21 | 40 | -11.11% |
| 31 Dec, 20 | 45 | - |
As of 30 Jun 24, 40 institutions are holding Spruce Biosciences's shares, representing a decrease of -24.53% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 16,573,655 | -7.76% |
| 31 Mar, 24 | 17,968,530 | -44.29% |
| 31 Dec, 23 | 32,256,406 | 1.16% |
| 30 Sep, 23 | 31,887,003 | -0.32% |
| 30 Jun, 23 | 31,989,915 | -3.90% |
| 31 Mar, 23 | 33,286,499 | 82.49% |
| 31 Dec, 22 | 18,240,391 | 1.12% |
| 30 Sep, 22 | 18,037,765 | 10.21% |
| 30 Jun, 22 | 16,366,425 | -4.24% |
| 31 Mar, 22 | 17,091,845 | -3.50% |
| 31 Dec, 21 | 17,711,654 | -9.82% |
| 30 Sep, 21 | 19,639,900 | -2.27% |
| 30 Jun, 21 | 20,096,228 | 6.51% |
| 31 Mar, 21 | 18,868,081 | -0.06% |
| 31 Dec, 20 | 18,878,630 | - |
Spruce Biosciences (SPRB) has 16.57M shares outstanding as of 30 Jun 24, down -7.76% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 40.33% | 2.10% |
| 31 Mar, 24 | 43.79% | 0.70% |
| 31 Dec, 23 | 79.23% | 1.28% |
| 30 Sep, 23 | 78.64% | 0.78% |
| 30 Jun, 23 | 100.28% | 0.92% |
| 31 Mar, 23 | 104.35% | 1.74% |
| 31 Dec, 22 | 77.53% | 1.32% |
| 30 Sep, 22 | 76.56% | 1.58% |
| 30 Jun, 22 | 69.66% | 1.32% |
| 31 Mar, 22 | 72.76% | 1.28% |
| 31 Dec, 21 | 75.52% | 1.07% |
| 30 Sep, 21 | 84.05% | 1.13% |
| 30 Jun, 21 | 86.14% | 1.31% |
| 31 Mar, 21 | 81.04% | 1.06% |
| 31 Dec, 20 | 87.64% | - |
As of 30 Jun 24, Spruce Biosciences is held by 40.33% institutional shareholders, representing a 2.10% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 10 | -68.75% |
| 31 Mar, 24 | 32 | 128.57% |
| 31 Dec, 23 | 14 | 7.69% |
| 30 Sep, 23 | 13 | -18.75% |
| 30 Jun, 23 | 16 | -38.46% |
| 31 Mar, 23 | 26 | 160.00% |
| 31 Dec, 22 | 10 | - |
| 30 Sep, 22 | 10 | - |
| 30 Jun, 22 | 10 | -16.67% |
| 31 Mar, 22 | 12 | -60.00% |
| 31 Dec, 21 | 30 | 42.86% |
| 30 Sep, 21 | 21 | -4.55% |
| 30 Jun, 21 | 22 | 37.50% |
| 31 Mar, 21 | 16 | -64.44% |
| 31 Dec, 20 | 45 | - |
10 institutional shareholders have increased their position in SPRB stock as of 30 Jun 24 compared to 32 in the previous quarter (a -68.75% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 15 | 87.50% |
| 31 Mar, 24 | 8 | -27.27% |
| 31 Dec, 23 | 11 | - |
| 30 Sep, 23 | 11 | - |
| 30 Jun, 23 | 11 | 10.00% |
| 31 Mar, 23 | 10 | 11.11% |
| 31 Dec, 22 | 9 | 12.50% |
| 30 Sep, 22 | 8 | -38.46% |
| 30 Jun, 22 | 13 | -27.78% |
| 31 Mar, 22 | 18 | 100.00% |
| 31 Dec, 21 | 9 | -43.75% |
| 30 Sep, 21 | 16 | 33.33% |
| 30 Jun, 21 | 12 | - |
| 31 Mar, 21 | 12 | - |
| 31 Dec, 20 | - | - |
15 institutional shareholders have reduced their position in SPRB stock as of 30 Jun 24 compared to 8 in the previous quarter (a 87.50% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 40 | -24.53% | 16,573,655 | -7.76% | 40.33% | 2.10% | 10 | -68.75% | 15 | 87.50% |
| 31 Mar, 24 | 53 | 32.50% | 17,968,530 | -44.29% | 43.79% | 0.70% | 32 | 128.57% | 8 | -27.27% |
| 31 Dec, 23 | 40 | -2.44% | 32,256,406 | 1.16% | 79.23% | 1.28% | 14 | 7.69% | 11 | - |
| 30 Sep, 23 | 41 | 2.50% | 31,887,003 | -0.32% | 78.64% | 0.78% | 13 | -18.75% | 11 | - |
| 30 Jun, 23 | 40 | -6.98% | 31,989,915 | -3.90% | 100.28% | 0.92% | 16 | -38.46% | 11 | 10.00% |
| 31 Mar, 23 | 43 | 43.33% | 33,286,499 | 82.49% | 104.35% | 1.74% | 26 | 160.00% | 10 | 11.11% |
| 31 Dec, 22 | 30 | -6.25% | 18,240,391 | 1.12% | 77.53% | 1.32% | 10 | - | 9 | 12.50% |
| 30 Sep, 22 | 32 | 3.23% | 18,037,765 | 10.21% | 76.56% | 1.58% | 10 | - | 8 | -38.46% |
| 30 Jun, 22 | 31 | -27.91% | 16,366,425 | -4.24% | 69.66% | 1.32% | 10 | -16.67% | 13 | -27.78% |
| 31 Mar, 22 | 43 | -14.00% | 17,091,845 | -3.50% | 72.76% | 1.28% | 12 | -60.00% | 18 | 100.00% |
| 31 Dec, 21 | 50 | 16.28% | 17,711,654 | -9.82% | 75.52% | 1.07% | 30 | 42.86% | 9 | -43.75% |
| 30 Sep, 21 | 43 | 4.88% | 19,639,900 | -2.27% | 84.05% | 1.13% | 21 | -4.55% | 16 | 33.33% |
| 30 Jun, 21 | 41 | 2.50% | 20,096,228 | 6.51% | 86.14% | 1.31% | 22 | 37.50% | 12 | - |
| 31 Mar, 21 | 40 | -11.11% | 18,868,081 | -0.06% | 81.04% | 1.06% | 16 | -64.44% | 12 | - |
| 31 Dec, 20 | 45 | - | 18,878,630 | - | 87.64% | - | 45 | - | - | - |
Spruce Biosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Spruce Biosciences's stock was made by Novo Holdings A/S on Mar 25 2024, selling 465,021 shares at $0.75 per share (valued at $350.95K).
Spruce Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 7 | - | - |
| Q1 2024 | 3 | 5 | 60.00% |
| Q4 2023 | 11 | 8 | 137.50% |
| Q2 2023 | 12 | 3 | 400.00% |
| Q1 2023 | 5 | 2 | 250.00% |
| Q4 2022 | 6 | - | - |
| Q2 2022 | 14 | 2 | 700.00% |
| Q1 2022 | 3 | 2 | 150.00% |
| Q4 2021 | 10 | - | - |
| Q2 2021 | 12 | 5 | 240.00% |
| Q1 2021 | 4 | - | - |
| Q4 2020 | 19 | 29 | 65.52% |
7 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Spruce Biosciences's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | 5 | - |
| Q4 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | 4 | - | - |
| Q4 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q2 2021 | - | 3 | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 9 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Spruce Biosciences's stocks.
SPRB Ownership FAQ
Who Owns Spruce Biosciences?
Spruce Biosciences is owned by institutional shareholders (40.33%), insiders (7.72%), and public (51.95%). The largest institutional shareholder of Spruce Biosciences is RIVERVEST VENTURE MANAGEMENT LLC (7.14% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.04% of total shares).
Who are the major institutional shareholders of Spruce Biosciences?
Spruce Biosciences's major institutional shareholders are RIVERVEST VENTURE MANAGEMENT LLC, CARLYLE GROUP INC., ROCK SPRINGS CAPITAL MANAGEMENT LP, ROSALIND ADVISORS, INC., and ACADIAN ASSET MANAGEMENT LLC. The top five shareholders own together 27.54% of the company's share outstanding.
How many Spruce Biosciences shareholders are there?
As of Jun 2024, there are 40 institutional shareholders of Spruce Biosciences.
What percentage of Spruce Biosciences is owned by RIVERVEST VENTURE MANAGEMENT LLC?
RIVERVEST VENTURE MANAGEMENT LLC owns 2.94M shares of Spruce Biosciences, representing 7.14% of the company's total shares outstanding, valued at $1.52M (as of Jun 2024).
What percentage of Spruce Biosciences is owned by CARLYLE GROUP INC?
As of Jun 2024, CARLYLE GROUP INC holds 2.9M shares of Spruce Biosciences (SPRB), compromising 7.05% of the company, valued at $1.52M.
What percentage of Spruce Biosciences is owned by ROCK SPRINGS CAPITAL MANAGEMENT LP?
ROCK SPRINGS CAPITAL MANAGEMENT LP is the third largest holder of Spruce Biosciences. The company owns 2.61M of the company's shares outstanding (worth $1.35M).